Dr. Mohamed Ali presents tirzepatide vs semaglutide fracture research at ASBMR
The BMC resident compared the two drugs on fracture risk in people with type 2 diabetes. He presented the work at the bone research meeting in Boston.
Recap by typeshit. Post by @bmcsouthtrack on Instagram.